BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16114280)

  • 1. Severe systemic complications of acromegaly.
    Colao A; Pivonello R; Marzullo P; Auriemma RS; De Martino MC; Ferone D; Lombardi G
    J Endocrinol Invest; 2005; 28(5 Suppl):65-77. PubMed ID: 16114280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
    Colao A; Ferone D; Marzullo P; Lombardi G
    Endocr Rev; 2004 Feb; 25(1):102-52. PubMed ID: 14769829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acromegaly and the cardiovascular system.
    Lombardi G; Galdiero M; Auriemma RS; Pivonello R; Colao A
    Neuroendocrinology; 2006; 83(3-4):211-7. PubMed ID: 17047385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular complications in acromegaly.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.
    Pivonello R; Auriemma RS; Grasso LF; Pivonello C; Simeoli C; Patalano R; Galdiero M; Colao A
    Pituitary; 2017 Feb; 20(1):46-62. PubMed ID: 28224405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep apnea and cardiovascular complications of the acromegaly. Response to the medical treatment.
    García-Álvarez M; Climent V
    Minerva Endocrinol; 2019 Jun; 44(2):159-168. PubMed ID: 30482010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sleep apnea syndromes and cardiovascular disease].
    Bounhoure JP; Galinier M; Didier A; Leophonte P
    Bull Acad Natl Med; 2005 Mar; 189(3):445-59; discussion 460-4. PubMed ID: 16149210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequelae to acromegaly: reversibility with treatment of the primary disease.
    Lieberman SA; Hoffman AR
    Horm Metab Res; 1990 Jun; 22(6):313-8. PubMed ID: 2199362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular pathology in acromegaly and some effects of the 90 yttrium implant in the hypophysis.
    Popovici D; Buteikis A; Handoca A; Bartoc R; Pîrvănescu L
    Endocrinologie; 1978; 16(3):223-8. PubMed ID: 694401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly.
    Fatti LM; Scacchi M; Pincelli AI; Lavezzi E; Cavagnini F
    Pituitary; 2001 Sep; 4(4):259-62. PubMed ID: 12501976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular involvement in patients affected by acromegaly: an appraisal.
    Mosca S; Paolillo S; Colao A; Bossone E; Cittadini A; Iudice FL; Parente A; Conte S; Rengo G; Leosco D; Trimarco B; Filardi PP
    Int J Cardiol; 2013 Sep; 167(5):1712-8. PubMed ID: 23219077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in acromegaly and in the normal population: prevalence and determinants.
    Vitale G; Pivonello R; Auriemma RS; Guerra E; Milone F; Savastano S; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):470-6. PubMed ID: 16181242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current thinking on the management of the acromegalic patient.
    Katznelson L
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):311-6. PubMed ID: 17940458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly.
    Powlson AS; Gurnell M
    Neuroendocrinology; 2016; 103(1):75-85. PubMed ID: 26227953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly.
    Delaroudis SP; Efstathiadou ZA; Koukoulis GN; Kita MD; Farmakiotis D; Dara OG; Goulis DG; Makedou A; Makris P; Slavakis A; Avramides AI
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):279-84. PubMed ID: 18194486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sleep apnea syndrome in patients with cardiac disease].
    Fujita K; Wada Y; Aono T; Sugi G; Ohta N; Sueda S; Nomoto T; Oshita A
    Rinsho Byori; 2008 Sep; 56(9):767-71. PubMed ID: 18975555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular diseases in obstructive sleep apnea.
    Dursunoğlu D; Dursunoğlu N
    Tuberk Toraks; 2006; 54(4):382-96. PubMed ID: 17203427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.